Both in Biotechnology
Invivyd vs Inhibikase Therapeutics
Over the past year IVVD returned −70.9% and IKT returned +10.2%; their daily moves had a correlation of 0.09.
IVVD −70.9% IKT +10.2%Growth of $1, one year, split-adjusted
| Metric | IVVD | IKT |
|---|---|---|
| Price | $0.6166 | $1.62 |
| Market cap | $181.7M | $226.0M |
| Today | +4.74% | +3.18% |
| 1 month | −27.5% | −19.8% |
| 6 months | −54.7% | −12.9% |
| Year to date | −75.0% | −21.0% |
| 1 year | −71.3% | +3.8% |
| Revenue growth (YoY) | +21.2% | — |
| Gross margin | 91.1% | — |
| Net margin | −310.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.1× | — |
| Net cash | $160.1M | $159.0M |
| Dividend yield | — | — |
| Volatility (60d) | 112.2% | 48.5% |
| Short % of float | 15.5% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).